no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Accelerometer measured physical activity and the integrity of the anterior visual pathway in multiple sclerosis
|
Sandroff, Brian M. |
|
2014 |
|
1 |
p. 117-122 6 p. |
article |
2 |
A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe
|
Giovannoni, Gavin |
|
2015 |
|
1 |
p. 83-84 2 p. |
article |
3 |
A review of the anterior visual pathway model and the study of vitamin D in demyelinating disease
|
Burton, Jodie M. |
|
2014 |
|
1 |
p. 22-27 6 p. |
article |
4 |
CD20+ T cells in multiple sclerosis
|
Schneider, Raphael |
|
2015 |
|
1 |
p. 58-59 2 p. |
article |
5 |
Cervical cord area measurement using volumetric brain magnetic resonance imaging in multiple sclerosis
|
Liu, Zheng |
|
2015 |
|
1 |
p. 52-57 6 p. |
article |
6 |
Cladribine tablets for relapsing–remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study
|
Rammohan, Kottil |
|
2012 |
|
1 |
p. 49-54 6 p. |
article |
7 |
Clinical course in multiple sclerosis patients presenting with a history of progressive disease
|
Pandey, K.S. |
|
2014 |
|
1 |
p. 67-71 5 p. |
article |
8 |
Cognitive change and neuroimaging following immunoablative therapy and hematopoietic stem cell transplantation in multiple sclerosis: A pilot study
|
Walker, L.A.S. |
|
2014 |
|
1 |
p. 129-135 7 p. |
article |
9 |
Concealed effects of gene–environment interactions in genome-wide association
|
Handel, Adam E. |
|
2012 |
|
1 |
p. 39-42 4 p. |
article |
10 |
Corrigendum to “Does Natalizumab treatment increase the risk of herpes simplex encephalitis in multiple sclerosis? Case and discussion” [Multiple Scler. Relat. Disord. 2 (4) (2013) 385–387]
|
Sharma, Kanchan |
|
2014 |
|
1 |
p. 136-137 2 p. |
article |
11 |
Disease activity free status in MS
|
Lublin, Fred D. |
|
2012 |
|
1 |
p. 6-7 2 p. |
article |
12 |
Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?
|
Fine, Debra |
|
2015 |
|
1 |
p. 88-91 4 p. |
article |
13 |
Editors' welcome
|
|
|
2014 |
|
1 |
p. 1-2 2 p. |
article |
14 |
Editor's Welcome
|
Banwell, Brenda |
|
2012 |
|
1 |
p. 1-2 2 p. |
article |
15 |
Editors׳ welcome
|
Banwell, Brenda |
|
2015 |
|
1 |
p. 1-2 2 p. |
article |
16 |
Epstein–Barr virus candidate genes and multiple sclerosis
|
Claire Simon, Kelly |
|
2015 |
|
1 |
p. 60-64 5 p. |
article |
17 |
Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond
|
Kipp, Markus |
|
2012 |
|
1 |
p. 15-28 14 p. |
article |
18 |
Fatigue, depression, and physical activity in relapsing-remitting multiple sclerosis: Results from a prospective, 18-month study
|
Motl, Robert W. |
|
2012 |
|
1 |
p. 43-48 6 p. |
article |
19 |
Health-related quality of life in patients with longstanding ‘benign multiple sclerosis’
|
Bueno, Anna-Marie |
|
2015 |
|
1 |
p. 31-38 8 p. |
article |
20 |
Integrity of hypothalamic fibers and cognitive fatigue in multiple sclerosis
|
Hanken, Katrin |
|
2015 |
|
1 |
p. 39-46 8 p. |
article |
21 |
Interleukin-2 effect on T cell activation revealed by daclizumab treatment
|
Sellebjerg, Finn |
|
2012 |
|
1 |
p. 8- 1 p. |
article |
22 |
Metabolic support of axons by oligodendrocytes: Implications for multiple sclerosis
|
Campbell, Graham R. |
|
2014 |
|
1 |
p. 28-30 3 p. |
article |
23 |
Molecular network of ChIP-Seq-based NF-κB p65 target genes involves diverse immune functions relevant to the immunopathogenesis of multiple sclerosis
|
Satoh, Jun-ichi |
|
2014 |
|
1 |
p. 94-106 13 p. |
article |
24 |
MSer – A new, neutral descriptor for someone with multiple sclerosis
|
Baker, David |
|
2014 |
|
1 |
p. 31-33 3 p. |
article |
25 |
MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review
|
Makhani, N. |
|
2014 |
|
1 |
p. 48-60 13 p. |
article |
26 |
Multiple sclerosis in children
|
Banwell, Brenda |
|
2012 |
|
1 |
p. 3-5 3 p. |
article |
27 |
Neurological comorbidity and survival in multiple sclerosis
|
Krökki, Olga |
|
2014 |
|
1 |
p. 72-77 6 p. |
article |
28 |
NMO spectrum disorders comprise the major portion of CNS inflammatory diseases in Thai patients: A cross sectional study
|
Apiwattanakul, Metha |
|
2014 |
|
1 |
p. 61-66 6 p. |
article |
29 |
No evidence for genetic association between glutamate transporter EAAT2 and Devic's neuromyelitis optica in caucasians and afro-caribbeans
|
Hanoux, Vincent |
|
2014 |
|
1 |
p. 89-93 5 p. |
article |
30 |
Optical coherence tomography in Susac's syndrome
|
Bernard, Jacqueline T. |
|
2014 |
|
1 |
p. 110-116 7 p. |
article |
31 |
Patients report worse MS symptoms after menopause: Findings from an online cohort
|
Bove, R. |
|
2015 |
|
1 |
p. 18-24 7 p. |
article |
32 |
Physical activity is associated with cognitive processing speed in persons with multiple sclerosis
|
Sandroff, Brian M. |
|
2014 |
|
1 |
p. 123-128 6 p. |
article |
33 |
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis
|
Amezcua, Lilyana |
|
2015 |
|
1 |
p. 25-30 6 p. |
article |
34 |
Positive neurologic phenomena with initiation of dalfampridine for multiple sclerosis
|
Thaera, Greg M. |
|
2014 |
|
1 |
p. 107-109 3 p. |
article |
35 |
Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse
|
Al-Izki, Sarah |
|
2012 |
|
1 |
p. 29-38 10 p. |
article |
36 |
Quantitative sensory and motor measures detect change over time and correlate with walking speed in individuals with multiple sclerosis
|
Zackowski, Kathleen M. |
|
2015 |
|
1 |
p. 67-74 8 p. |
article |
37 |
Risk associated behavior in premorbid multiple sclerosis: A case-control study
|
Hawkes, Christopher H. |
|
2014 |
|
1 |
p. 40-47 8 p. |
article |
38 |
Self-reported severity among patients with multiple sclerosis in the U.S. and its association with health outcomes
|
Gupta, Shaloo |
|
2014 |
|
1 |
p. 78-88 11 p. |
article |
39 |
Serum BDNF levels are not reliable correlates of neurodegeneration in MS patients
|
Damasceno, Alfredo |
|
2015 |
|
1 |
p. 65-66 2 p. |
article |
40 |
Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes
|
Bernitsas, Evanthia |
|
2015 |
|
1 |
p. 47-51 5 p. |
article |
41 |
Sustained-release fampridine in Multiple Sclerosis
|
Hadavi, S. |
|
2014 |
|
1 |
p. 17-21 5 p. |
article |
42 |
The diagnostic criteria for multiple sclerosis: From Charcot to McDonald
|
Gafson, Arie |
|
2012 |
|
1 |
p. 9-14 6 p. |
article |
43 |
The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS)
|
Alwan, Sura |
|
2015 |
|
1 |
p. 6-17 12 p. |
article |
44 |
The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
|
Giovannoni, Gavin |
|
2015 |
|
1 |
p. 3-5 3 p. |
article |
45 |
Therapy Optimization in Multiple Sclerosis: A cohort study of therapy adherence and risk of relapse
|
Cohen, B.A. |
|
2015 |
|
1 |
p. 75-82 8 p. |
article |
46 |
Useless hand syndrome with astereognosis in multiple sclerosis
|
Kamogawa, Kenji |
|
2015 |
|
1 |
p. 85-87 3 p. |
article |
47 |
Vision and multiple sclerosis
|
Hickman, Simon J. |
|
2014 |
|
1 |
p. 3-16 14 p. |
article |
48 |
Vitamin A is not associated with exacerbations in multiple sclerosis
|
Runia, T.F. |
|
2014 |
|
1 |
p. 34-39 6 p. |
article |